DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER: NUMBER NEEDED TO TREAT, NUMBER NEEDED TO HARM & LIKELIHOOD TO BE HELPED OR HARMED

被引：0

作者：

Chalet, Francois-Xavier ^{[1
]}

Luyet, Pierre-Philippe ^{[1
]}

Rabasa, Cristina ^{[1
]}

Vaillant, Cedric ^{[1
]}

Saskin, Paul ^{[1
]}

Ahuja, Ajay ^{[1
]}

Citrome, Leslie ^{[2
]}

机构：

[1] Idorsia Pharmaceut, Radnor, PA USA

[2] New York Med Coll, Valhalla, NY USA

来源：

SLEEP | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

0350

引用

下载

页码：A155 / A155

页数：1

共 50 条

[21] Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed
Citrome, Leslie
DiBernardo, Allitia
Singh, Jaskaran
JOURNAL OF AFFECTIVE DISORDERS, 2020, 271 : 228 - 238
[22] Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed
Ketter, T. A.
Citrome, L.
Cucchiaro, J.
Loebel, A.
BIPOLAR DISORDERS, 2013, 15 : 92 - 92
[23] Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed
Citrome, Leslie
Ketter, Terence A.
Cucchiaro, Josephine
Loebel, Antony
JOURNAL OF AFFECTIVE DISORDERS, 2014, 155 : 20 - 27
[24] Clinical Assessment of Lurasidone Benefit and Risk in the Treatment of Bipolar I Depression Using Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Citrome, Leslie
Ketter, Terence A.
Cucchiaro, Josephine
Loebel, Antony
NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S359 - S361
[25] Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed
Citrome, Leslie
JOURNAL OF AFFECTIVE DISORDERS, 2016, 196 : 225 - 233
[26] Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (04) : 356 - 368
[27] Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (11) : 1089 - 1104
[28] Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (01) : 60 - 82
[29] Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (04) : 410 - 421
[30] Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medicationWhat is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, Leslie
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (11)

← 1 2 3 4 5 →